532 related articles for article (PubMed ID: 31883160)
1. MicroRNA-493-5p-mediated repression of the MYCN oncogene inhibits hepatic cancer cell growth and invasion.
Yasukawa K; Liew LC; Hagiwara K; Hironaka-Mitsuhashi A; Qin XY; Furutani Y; Tanaka Y; Nakagama H; Kojima S; Kato T; Ochiya T; Gailhouste L
Cancer Sci; 2020 Mar; 111(3):869-880. PubMed ID: 31883160
[TBL] [Abstract][Full Text] [Related]
2. miR-425-5p Acts as a Molecular Marker and Promoted Proliferation, Migration by Targeting RNF11 in Hepatocellular Carcinoma.
Rao D; Guan S; Huang J; Chang Q; Duan S
Biomed Res Int; 2020; 2020():6530973. PubMed ID: 33123581
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
[TBL] [Abstract][Full Text] [Related]
4. microRNA-93-5p promotes hepatocellular carcinoma progression via a microRNA-93-5p/MAP3K2/c-Jun positive feedback circuit.
Shi X; Liu TT; Yu XN; Balakrishnan A; Zhu HR; Guo HY; Zhang GC; Bilegsaikhan E; Sun JL; Song GQ; Weng SQ; Dong L; Ott M; Zhu JM; Shen XZ
Oncogene; 2020 Aug; 39(35):5768-5781. PubMed ID: 32719439
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways.
Yan X; Zhu Z; Xu S; Yang LN; Liao XH; Zheng M; Yang D; Wang J; Chen D; Wang L; Liu X; Liu J; Chen RH; Zhou XZ; Lu KP; Liu H
Sci Rep; 2017 Apr; 7():45915. PubMed ID: 28383568
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA Fer-1-like protein 4 acts as a tumor suppressor via miR-106a-5p and predicts good prognosis in hepatocellular carcinoma.
Wu J; Huang J; Wang W; Xu J; Yin M; Cheng N; Yin J
Cancer Biomark; 2017 Jul; 20(1):55-65. PubMed ID: 28759956
[TBL] [Abstract][Full Text] [Related]
7. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.
Hua S; Lei L; Deng L; Weng X; Liu C; Qi X; Wang S; Zhang D; Zou X; Cao C; Liu L; Wu D
Oncogene; 2018 Mar; 37(12):1624-1636. PubMed ID: 29335523
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-1251-5p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting AKAP12.
Han S; Wang L; Sun L; Wang Y; Yao B; Chen T; Liu R; Liu Q
Biomed Pharmacother; 2020 Feb; 122():109754. PubMed ID: 31918285
[TBL] [Abstract][Full Text] [Related]
9. Down-regulated miR-28-5p in human hepatocellular carcinoma correlated with tumor proliferation and migration by targeting insulin-like growth factor-1 (IGF-1).
Shi X; Teng F
Mol Cell Biochem; 2015 Oct; 408(1-2):283-93. PubMed ID: 26160280
[TBL] [Abstract][Full Text] [Related]
10. LncRNA MIR22HG inhibits growth, migration and invasion through regulating the miR-10a-5p/NCOR2 axis in hepatocellular carcinoma cells.
Wu Y; Zhou Y; Huan L; Xu L; Shen M; Huang S; Liang L
Cancer Sci; 2019 Mar; 110(3):973-984. PubMed ID: 30680848
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
Quan H; Li B; Yang J
Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
[TBL] [Abstract][Full Text] [Related]
12. SNHG7 Facilitates Glioblastoma Progression by Functioning as a Molecular Sponge for MicroRNA-449b-5p and Thereby Increasing MYCN Expression.
Chen Y; Yuan S; Ning T; Xu H; Guan B
Technol Cancer Res Treat; 2020; 19():1533033820945802. PubMed ID: 32720593
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-769-5p contributes to the proliferation, migration and invasion of hepatocellular carcinoma cells by attenuating RYBP.
Xian Y; Wang L; Yao B; Yang W; Mo H; Zhang L; Tu K
Biomed Pharmacother; 2019 Oct; 118():109343. PubMed ID: 31545279
[TBL] [Abstract][Full Text] [Related]
14. MEG3-derived miR-493-5p overcomes the oncogenic feature of IGF2-miR-483 loss of imprinting in hepatic cancer cells.
Gailhouste L; Liew LC; Yasukawa K; Hatada I; Tanaka Y; Kato T; Nakagama H; Ochiya T
Cell Death Dis; 2019 Jul; 10(8):553. PubMed ID: 31320614
[TBL] [Abstract][Full Text] [Related]
15. Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma.
Buechner J; Tømte E; Haug BH; Henriksen JR; Løkke C; Flægstad T; Einvik C
Br J Cancer; 2011 Jul; 105(2):296-303. PubMed ID: 21654684
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma.
Duan X; Li W; Hu P; Jiang B; Yang J; Zhou L; Mao X; Tian B
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33078826
[TBL] [Abstract][Full Text] [Related]
18. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).
Zhu Q; Gong L; Wang J; Tu Q; Yao L; Zhang JR; Han XJ; Zhu SJ; Wang SM; Li YH; Zhang W
BMC Cancer; 2016 Oct; 16(1):806. PubMed ID: 27756250
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
[TBL] [Abstract][Full Text] [Related]
20. Astemizole promotes the anti-tumor effect of vitamin D through inhibiting miR-125a-5p-meidated regulation of VDR in HCC.
Xu J; Wang Y; Zhang Y; Dang S; He S
Biomed Pharmacother; 2018 Nov; 107():1682-1691. PubMed ID: 30257386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
